• In late June 2026, USA Rare Earth, Inc. (NasdaqGM: USAR) was removed from several Russell value-focused benchmarks, while also facing an MP Materials lawsuit over alleged misappropriation of rare earth processing technology and commissioning a new hydrometallurgical demonstration facility backed by U.S. Department of Commerce agreements.
• The combination of index removals, legal scrutiny around proprietary magnet technology and progress toward an integrated domestic rare earth supply chain underscores how central USA Rare Earth has become to efforts to localize critical materials production outside China.
• We’ll now examine how the MP Materials lawsuit and related technology questions could influence USA Rare Earth’s evolving investment narrative.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

USA Rare Earth Investment Narrative Recap

To own USA Rare Earth, you need to believe in its plan to build a fully integrated rare earth supply chain for ex China customers, from Round Top ore through magnets. In the near term, the key catalyst is moving from commissioning to meaningful oxide and magnet production, while the biggest risk remains execution and funding for a still loss making, capital intensive buildout. The Russell index removals and the MP Materials lawsuit highlight volatility but do not, by themselves, change that core thesis.

The most relevant recent announcement here is the commissioning of the hydrometallurgical demonstration facility in Wheat Ridge, Colorado, which is supported by U.S. Department of Commerce agreements. This step is important because it tests processing routes for Round Top ore, third party concentrates and swarf recycling, all linked to the same integrated model that the lawsuit and index changes now put under a brighter spotlight for investors.

Yet behind the promise of a government backed, integrated rare earth chain, investors should also be aware of the legal and funding uncertainty around...

USA Rare Earth's narrative projects $713.4 million revenue and $102.7 million earnings by 2029. This implies moving from no revenue today to $713.4 million by 2029, and an earnings increase of about $388 million from -$285.4 million today.

Uncover how USA Rare Earth's forecasts yield a $38.60 fair value, a 102% upside to its current price.

Exploring Other Perspectives

Before this lawsuit and index removal, the most optimistic analysts were modeling revenue above US$1.4 billion and earnings near US$239 million, which is far more upbeat than the current execution and funding risks suggest, so it is worth asking how those expectations around rapid capacity buildout might shift as this new legal and competitive pressure plays out.

Explore 16 other fair value estimates on USA Rare Earth - why the stock might be worth over 4x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your USA Rare Earth research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free USA Rare Earth research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate USA Rare Earth's overall financial health at a glance.

Ready For A Different Approach?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
• Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.